Insightful Science rebrands to Dotmatics  

Software company Insightful Science has announced it is retiring its brand name and will go forward under the name Dotmatics. 

The rebrand follows the merger of Insightful Science and Dotmatic in 2021 and the organisation now has a global team of over 800 employees, supporting customers in more than 180 countries.  

Dotmatics has recently added strategic executive hires including a CFO, CRO, and CMO and will continue to build and acquire leading scientific software applications in areas of lab research. The organisation now offers capabilities to advance R&D productivity through its platform that connects and organises data which gets distributed across organizations or industries and combines it with market-leading science applications for quick access, collaboration, and informed decision-making.  

The company’s Dotmatics’ enterprise scientific platform connects researchers with a range of applications, offering end-to-end solutions for biology, chemistry, and formulations research and development. 

 Official comments  

Companies that own the cleanest, best annotated data to power their AI analytics and decision making will be the best positioned to succeed in this new paradigm,” said Thomas Swalla, CEO of Dotmatics. “We are going to market under the consolidated brand Dotmatics reflecting the enormous power of the Company to provide this capability to our customers. We can transform scientific R&D with a platform that addresses the data challenges and then connects industry-favourite applications to better harmonise science and data.” 

“Our combined team of 800+ employees at Dotmatics are working together to eliminate the workarounds and decision-making challenges scientists are facing in today’s market,” said Mike McKee, President of Dotmatics. “Today we are helping to solve these challenges for companies like BAS-F, Merck, and Novartis Pharma AG and research universities like MIT and Oxford, providing them with solutions that harmonise science and data to create a better future together.”  

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free